Marie Quinn
Roswell Park Comprehensive Cancer Center(US)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Breast Lesions and Carcinomas, Liver Diseases and Immunity, Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses
Most-Cited Works
- → Phase 1, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Intravenous Alvespimycin (KOS-1022) in Patients with Refractory Hematological Malignancies.(2006)17 cited
- → Options to Determine Pathological Response of Axillary Lymph Node Metastasis after Neoadjuvant Chemotherapy in Advanced Breast Cancer(2021)12 cited
- → Atypical Ductal Hyperplasia and Those Bordering on Ductal Carcinoma In Situ Should Be Included in the Active Surveillance Clinical Trials(2019)12 cited
- → Touching tumour‐infiltrating lymphocytes in low‐risk ductal carcinoma in situ (DCIS) correlate with upgrading to high‐grade DCIS(2021)11 cited
- → Significance of Removing Comedonecrosis as an Exclusion Criterion in Mammary Low-Risk Ductal Carcinoma In Situ Managed in an Active Surveillance Clinical Trial(2020)6 cited
- → 189 Intra-operative lymph node assessment in lung cancer resection(2012)
- → 321 Phase I clinical trial assessing the combination of systemic chemokine modulatory regimen targeting TLR3 with neoadjuvant chemotherapy in triple negative breast cancer(2020)